NASDAQ OMX

PwC: CEO confidence rises despite new risks and uncertainty

16.1.2017 18:30 | NASDAQ OMX

Del
  • Confidence in company growth rises
  • Fifty two per cent of CEOs plan to increase number of jobs
  • Concerns about over regulation and lack of key skills at record levels
  • CEOs feel globalisation has done little to solve income inequality

DAVOS, Switzerland, Jan. 16, 2017 (GLOBE NEWSWIRE) -- While CEOs around the world feel they have plenty to worry about in the year ahead, their confidence in their own growth prospects and their outlook for the global economy are back on the rise.

Graphics accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/77eaac3e-f05b-4fc2-b82a-ee926f9078e1

http://www.globenewswire.com/NewsRoom/AttachmentNg/f27a6ebc-f247-494a-bb07-e4507f11b772

In PwC’s 20th annual survey of CEOs worldwide, 38% (2016: 35%) are very confident about their company’s growth prospects in the next 12 months while 29% (2016:27%) believe global economic growth will pick up in 2017.

The findings released today at the World Economic Forum in Davos show that while business leaders are more positive in their outlook, their levels of concern about economic uncertainty (82%), over-regulation (80%), availability of key skills (77%) remain very high. Also worries about protectionism are growing, with 59% of CEO concerned about protectionism, increasing to 64% for CEOs in the United States and Mexico.

While positive on the benefits of globalisation in building the free movement of capital, goods, and people, CEOs question whether globalisation has done anything to close the gap between rich and poor or mitigated the issue of climate change. This is in contrast to the first PwC CEO survey in 1998 when CEOs were positive about the drivers of globalisation.

Bob Moritz, Global Chairman, PwC, comments:

“Despite a tumultuous 2016, CEO confidence is moving back up – albeit slowly and still a long way from the levels we saw back in 2007. But there are signs of optimism right across the globe, including in the UK and US, where despite predictions of a Trump slump and a Brexit exit, CEOs confidence in their company’s growth are up from 2016. And that mood is reflected elsewhere, with more CEOs across the world targeting the US and UK for investment than a year ago.

“While CEOs are more confident in the opportunity for growth, this year they told us these three concerns that were top of mind: a people and technology strategy that creates a workforce fit for the digital age; preserving trust in their businesses in a world of increasingly virtual interactions; and making globalisation work for everyone by engaging ever more with society and collaborating to find solutions. All topics that will be high up the Davos agenda.”

Confidence in revenue growth climbs
In sharp contrast to 2016, CEO’s confidence in their own one year revenue growth is on the rise in nearly every major country across the world…with India (71%), Brazil, where confidence levels have more than doubled (57%), Australia (43%) and the UK (41%) topping the table. Confidence also rose by 11 points in China to 35%, 6 points in the US to 39% and 3 points in Germany to 31%. In Switzerland confidence levels have more than doubled to 34%.

Bucking the confidence trend are Mexico and Japan where confidence levels have dropped, markedly so in Japan where confidence has plunged from 28% in 2016 to 14% today.

When asked what drives growth, organic expansion tops the agenda for over three quarters of CEOs (79%) in the coming year, while 41% are planning new merger and acquisition activity in 2017 and nearly a quarter (23%) of all CEOs intend to strengthen their innovation capabilities to capitalise on new opportunities.

Where CEOs will look for growth
PwC’s first global CEO survey showed emerging markets ‑ including China and India ‑ as a sure bet for success. But the changeability of markets, exacerbated by currency volatility, has caused CEOs to turn to a greater mix of countries. This year’s survey shows the US, Germany and the UK have become bigger priorities, while enthusiasm for investing in Brazil, India, Russia and Argentina has lessened from three years ago.

The top five most important countries for growth identified are the US (1), China (2), Germany (3), the UK (4) and Japan (5) with the UK rising in popularity as a growth destination with CEOs from the US (+4%), China (+11%), Germany (+8%) and Switzerland (+25%).

Shanghai, New York, London, and Beijing were also identified as the top four cities most important to an organization’s overall growth prospects over the next 12 months.

Globalisation
58% of business leaders think it’s become harder to balance globalisation with rising trends in protectionism. The concerns contrast with their views in the first PwC CEO survey which reported ‘the typical global corporation has as much freedom of trade as it needs’.

For the past 20 years CEOs have been largely positive about the contribution of globalisation to the free movement of capital, goods, and people. However, this year’s survey respondents are sceptical that it has mitigated climate change or helped close the gap between rich and poor. This is similar to the public’s view on these issues in a separate consumer poll commissioned by PwC of over 5000 people in 22 countries.

Only 38% of the public believed globalisation has had a largely positive impact on improving the movement of capital, people, goods and information, compared with 60% of CEOs. Almost two thirds (64%) of the public believe globalisation has helped create full and meaningful employment, contrasting with over three quarters of CEOs (76%). The public are also less convinced than business leaders that globalisation has created, to a large extent, a skilled and educated workforce (29% of the public vs 37% of CEOs).

“Public discontent has the potential to erode trust which is needed for long term sustainable performance. The real challenge here though, isn’t just one of how CEOs navigate, it’s about the need for CEOs to have a deeper, two-way relationship with stakeholders, customers, employees, and the public. Understanding the root cause of the potential discontent or perception is a critical first step towards communicating the benefits of business for society. There’s a lot at stake if we do not achieve inclusive global growth,” comments Bob Moritz.

Technology and Trust
CEOs tell us that technology is now inseparable from business’ reputation, skills and recruitment, competition and growth. Almost a quarter believe technology will completely reshape competition in their industry over the next five years (23%).

In an increasingly digital-driven world, technology has created a new dynamic between business and customers bringing huge benefits for both.  However on the flip side 69% of CEOs say it is harder to gain and keep people’s trust in this environment and 87% believe risks from use of social media could have a negative impact on the level of trust in their industry.  91% of CEOs also agree data privacy and ethics issues could impact people’s trust in their organisations in the next five years.

Twenty years ago, trust wasn’t high on the business radar for CEOs. 15 years ago only 12% of CEOs thought public trust in companies had greatly declined. This year, 58% worry that a lack of trust in business will harm their company’s growth, up from 37% in 2013.

After several high-profile technology and security issues for big companies, CEOs unsurprisingly identify cyber security, data privacy breaches and IT disruptions as the top three technology threats to stakeholder trust.

“CEOs expect it to become harder to sustain trust in the digital era. But competitive advantage will go to those with the greatest capacity to turn technology into their strength when coupled with the ability to connect with their stakeholders in an on-going relationship grounded in trust,” added Bob Moritz.

Skills and jobs
Concern about skills has more than doubled in 20 years (from 31% concerned in 1998 to 77% in 2017) and human capital is a top three business priority, with diversity and inclusiveness and workforce mobility amongst the strategies being used to address future skills needs. Skills availability is a concern for over three quarters (77%) of business leaders, and is highest for CEOs in Africa (80%), and Asia Pacific (82%).

Over half of CEOs (52% vs 48% 2016) expect to increase headcount over next 12 months. The UK (63%), China (60%), India (67%) and Canada (64%) are amongst those with the most ambitious hiring plans.  Looking by industry it is CEOs in the Asset Management (64%), Healthcare (64%) and Technology (59%) that have the most ambitious hiring plans, with CEOs in the Government and public sector (32%) having the least.

While only 16% of business leaders surveyed expect to reduce their overall employee base, CEOs say that 80% of those affected jobs will be impacted in some way by the use of technology or automation. Business leaders in Canada (100%), US (95%), Germany (93%), Australia (92%), and Brazil (91%) see technology having the greatest impact.

Over half of business leaders interviewed (52%) are already exploring the benefits of how humans and machines can work together, and two out five (39%) are considering the impact of artificial intelligence on future skills needs.

With the speed of technological change a concern for 70% of CEOs, it’s no surprise that skills in creativity and innovation, leadership and emotional intelligence are identified as the most valuable skills, that CEOs are finding it difficult to recruit. Digital and STEM skills are a recruitment issue for over half of business leaders.

Bob Moritz, Global Chairman, PwC concludes:

"CEO's are concerned that key skill shortages will impair their company’s growth potential, relevance and sustainability.  And it's soft skills that they value the most. Innovation and relationship skills can't be coded.  So to drive the change CEOs need - thinking carefully and actioning accordingly – a balance between technology and irreplaceable skills in their people is key.  Managing expectations with stakeholders will help enable the needed trust to survive and thrive. Bottom line - prioritizing the human element in a more virtual world will be a pre-requisite for future success.”

Notes to editors:

  1. This survey was carried out between September and December 2016. 1379 CEOs responded from 79 countries, to online, postal, face to face and phone interviews. 57% worked in privately owned companies, 43% in publicly listed companies. 36% worked at companies with revenues over $1bn PA; 38% between $101-$999bn PA; and 21% with revenues of less than $100m.
  2. Growth confidence: The highest levels of confidence in 12 month growth for companies was recorded in 2007 – 52% of CEOs said they were very confidence of growth in the next 12 months. The lowest was in 2009 (21%). The highest levels of three year confidence previously recorded was 51% of CEOs (very confident) in 2011, similar to this year’s survey. 2014 recorded the highest ever levels of CEO confidence in global economic growth improving (44%).
  3. The public survey took place in December in 22 countries - USA, Canada, UK, France, Germany, Netherlands, China & Hong Kong, Italy, Spain, Russia, Australia, Japan, India, Brazil, South Korea, Mexico, Sweden, Switzerland, South Africa, Singapore, and United Arab Emirates.
  4. List of country/regional CEO saying they are very confident of 12 month growth.
Very confident of short-term revenue growth
  2017 2016 2015 2014
India 71 % 64 % 62 % 49 %
Brazil 57 % 24 % 30 % 42 %
Romania 52 % 50 % 44 % 39 %
Spain 50 % 54 % 35 % 23 %
Australia 43 % 35 % 43 % 34 %
UK 41 % 33 % 39 % 27 %
Argentina 40 % 42 % 17 % 10 %
US 39 % 33 % 46 % 36 %
Denmark 39 % 30 % 33 % 44 %
Mexico 38 % 46 % 50 % 51 %
Global 38 % 35 % 39 % 39 %
Canada 38 % 31 % 36 % 27 %
Italy 38 % 20 % 20 % 27 %
Nordic 37 % 31 % 26 % ***
China 35 % 24 % 36 % 48 %
Switzerland 34 % 16 % 24 % 42 %
South Africa 33 % 37 % 39 % 25 %
ASEAN** 32 % 38 % 47 % 45 %
Germany 31 % 28 % 35 % 33 %
Russia 31 % 26 % 16 % 53 %
Africa* 28 % 42 % *** ***
Hong Kong 27 % *** *** ***
Japan 14 % 28 % 27 % 27 %
Venezuela 13 % *** *** ***

*    Africa excludes South Africa
**  The ASEAN countries in which interviews were conducted are: Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand and Vietnam 
*** Not available

  1. List of CEOs planning job increases by industry.
Percentage of CEOs expected to boost headcount
  2017 2016 2015 2014
Asset and  Wealth Management 64 % 65 % 61 % 58 %
Healthcare 64 % 56 % 59 % 53 %
Technology 59 % 67 % 55 % 63 %
Business services 57 % 51 % 56 % 62 %
Hospitality & Leisure 55 % 53 % 45 % 51 %
Mining 55 % 45 % 52 % 25 %
Industrial Manufacturing 54 % 47 % 53 % 46 %
Retail 53 % 51 % 46 % 51 %
Transport & Logistics 53 % 51 % 49 % 40 %
Communications 51 % 48 % 40 % 52 %
Power & Utilities 51 % 42 % 36 % 36 %
Engineering & Construction 50 % 42 % 51 % 51 %
Entertainment & Media 48 % 39 % 46 % 53 %
Pharmaceuticals & Life Sciences 46 % 64 % 58 % 44 %
Banking & Capital Markets 45 % 43 % 53 % 52 %
Automotive 43 % 48 % 49 % 45 %
Insurance 41 % 49 % 50 % 59 %
Metals 41 % 32 % 41 % 22 %
Energy (includes Oil & Gas) 41 % *** *** ***
Chemicals 40 % 46 % 50 % 49 %
Consumer Goods 40 % 41 % 40 % 46 %
Forest, Paper & Packaging 35 % 36 % 27 % 45 %
Government/public services 32 % *** *** ***

*** Not available

About PwC 
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 157 countries with more than 223,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.

PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

© 2017 PwC. All rights reserved

         Contact:
         Mike Davies (on site at Davos), PwC
         Mobile: +44 7803 974 136
         Email: mike.davies@pwc.com
         
         More details: http://press.pwc.com, ceosurvey.pwc
         Follow/retweet: @pwc

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Hminers Disrupts the Cryptocurrency Market with Powerful, Multi-Algorithm Mining Rigs18.8.2017 11:00Pressemelding

Hminers continues to hit the headlines in the rapidly expanding global market for cryptocurrency. The Miami-based company has recently introduced three extremely powerful, multi-algorithm mining rigs that have been designed to provide maximum hash rate with minimum power consumption. MIAMI, Aug. 18, 2017 (GLOBE NEWSWIRE) -- In their relentless efforts to deliver state-of-the-art products related to cryptocurrency, Hminers has recently launched three brilliantly designed bitcoin mining rigs. The unique features and capabilities of the company's new H2U Miner, H4U Miner, and Rack Equipped with 5 x H4U have already grabbed the attention of the cryptocurrency enthusiasts and experts around the world. An organization with a rich tradition, Hminers (www.hminers.com) is recognized in the industry as the creator of the first ever 10 nm ASIC Chip in the world. Cryptocurrency mining is the process of generating new cryptocurrency that requires a pot

Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market17.8.2017 18:50Pressemelding

NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market.  I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India. "Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now,

Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30Pressemelding

WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00Pressemelding

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions   RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium  DR Capsules 49.3 mg  in the coming weeks   Esomeprazole Strontium  DR Capsules 49.3 mg  will be the third commercial GI product to be promoted by RedHill in the U.S.    RedHill's GI-focused sales force currently promotes two GI s

Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40Pressemelding

Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid

Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A16.8.2017 15:38Pressemelding

NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today announced the pivotal expansion of its gene therapy clinical trials for patients with MPS IIIA in the USA, Europe and Australia. "We have completed the necessary regulatory and ethical committee approvals and site initiations in Europe and Australia in order to accelerate enrollment," stated Juan Ruiz, M.D., Ph.D., Abeona's Chief Medical Officer. "We remain very encouraged by the improvements observed in clinically relevant biomarkers post-dosing of ABO-102, including durable reductions in heparan sulfate measured in the CNS, reduction of organ disease pathology, and signals of CNS improvement or stabilization at one-year follow-up in Cohort 1 subjects, and look forward to providing a more fulsome clinical update at important clinical

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom